scholarly article | Q13442814 |
P50 | author | Barbara J. Stoll | Q64689168 |
Betty Vohr | Q90431154 | ||
Susan R Hintz | Q104459156 | ||
Rosemary D. Higgins | Q120839249 | ||
P2093 | author name string | Ira Adams-Chapman | |
National Institute of Child Health and Human Development Neonatal Research Network | |||
Nellie I Hansen | |||
Avroy A Fanaroff | |||
P433 | issue | 19 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2357-2365 | |
P577 | publication date | 2004-11-01 | |
P1433 | published in | The Journal of the American Medical Association | Q1470970 |
P1476 | title | Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection | |
P478 | volume | 292 |
Q42683892 | "They've walked in my shoes": mothers of very low birth weight infants and their experiences with breastfeeding peer counselors in the neonatal intensive care unit |
Q46253117 | (1-3)-β-D-glucan levels in candidiasis infections in the critically ill neonate. |
Q41745449 | A "multi-hit" model of neonatal white matter injury: cumulative contributions of chronic placental inflammation, acute fetal inflammation and postnatal inflammatory events |
Q34076865 | A pilot study to determine the safety and feasibility of oropharyngeal administration of own mother's colostrum to extremely low-birth-weight infants |
Q33269762 | A potential biomarker in the cord blood of preterm infants who develop retinopathy of prematurity |
Q88323865 | A protocol for quality improvement programme to reduce central line-associated bloodstream infections in NICU of low and middle income country |
Q40297215 | A quality improvement initiative to reduce central line infection in neonates using checklists |
Q37681543 | A quality improvement initiative to reduce central line-associated bloodstream infections in a neonatal intensive care unit |
Q47386796 | A randomised trial of enteral glutamine supplementation for very preterm children showed no beneficial or adverse long-term neurodevelopmental outcomes. |
Q28710149 | A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: outcomes at 2 years |
Q39919269 | A silver-alginate-coated dressing to reduce peripherally inserted central catheter (PICC) infections in NICU patients: a pilot randomized controlled trial |
Q38104329 | A systematic review of strategies for reporting of neonatal hospital-acquired bloodstream infections. |
Q42656911 | A toolkit for monitoring hospital-acquired bloodstream infection in neonatal intensive care. |
Q48166154 | Academic performance of children born preterm: a meta-analysis and meta-regression. |
Q39000801 | Access to Obstetric Care and Children's Health, Growth and Cognitive Development in Vietnam: Evidence from Young Lives. |
Q36723209 | Active Surveillance Cultures and Decolonization to Reduce Staphylococcus aureus Infections in the Neonatal Intensive Care Unit |
Q40135948 | Active Surveillance Cultures and Targeted Decolonization Are Associated with Reduced Methicillin-Susceptible Staphylococcus aureus Infections in VLBW Infants |
Q35926313 | Adverse consequences of neonatal antibiotic exposure |
Q38976418 | Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures. |
Q36754959 | Age-specific percentile-based reference curve of serum procalcitonin concentrations in Japanese preterm infants |
Q55516298 | Amino Acid-Based Formula in Premature Infants with Feeding Intolerance: Comparison of Fecal Calprotectin Level. |
Q91951365 | An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlle |
Q38059806 | An overview of risk factors for poor neurodevelopmental outcome associated with prematurity. |
Q35787820 | Antenatal antecedents of cognitive impairment at 24 months in extremely low gestational age newborns |
Q60112422 | Anti-Cytokine Therapy to Attenuate Ischemic-Reperfusion Associated Brain Injury in the Perinatal Period |
Q52610288 | Antibiotic Overuse in Premature Low-Birth-Weight Infants in a Developing Country. |
Q27003877 | Antibiotic use and misuse in the neonatal intensive care unit |
Q50420561 | Antibiotics at the time of removal of central venous catheter to reduce morbidity and mortality in newborn infants |
Q24185833 | Antibiotics at the time of removal of central venous catheter to reduce morbidity and mortality in newborn infants |
Q24186985 | Antimicrobial-impregnated central venous catheters for prevention of catheter-related bloodstream infection in newborn infants |
Q24194919 | Antimicrobial-impregnated central venous catheters for prevention of catheter-related bloodstream infection in newborn infants |
Q64109870 | Antimicrobial-impregnated central venous catheters for prevention of neonatal bloodstream infection (PREVAIL): an open-label, parallel-group, pragmatic, randomised controlled trial |
Q26750492 | Antiseptic use in the neonatal intensive care unit - a dilemma in clinical practice: An evidence based review |
Q24240966 | Antistaphylococcal immunoglobulins to prevent staphylococcal infection in very low birth weight infants |
Q24245987 | Antistaphylococcal immunoglobulins to prevent staphylococcal infection in very low birth weight infants |
Q94588767 | Application of metabolomics to neonatal meningitis |
Q50045044 | Assessing cerebrovascular autoregulation in infants with necrotizing enterocolitis using near-infrared spectroscopy. |
Q89502776 | Assessment of C-Reactive Protein Diagnostic Test Accuracy for Late-Onset Infection in Newborn Infants: A Systematic Review and Meta-analysis |
Q34338921 | Association between feeding difficulties and language delay in preterm infants using Bayley Scales of Infant Development-Third Edition |
Q36806305 | Association between hospital recognition for nursing excellence and outcomes of very low-birth-weight infants |
Q40741111 | Association between neonatal morbidities and head growth from birth until discharge in very-low-birthweight infants born preterm: a population-based study |
Q53419675 | Association of Histologic Chorioamnionitis With Perinatal Brain Injury and Early Childhood Neurodevelopmental Outcomes Among Preterm Neonates. |
Q47173093 | Association of Intralipid Intake in Extremely Low Birth Weight Infants with Neurodevelopmental Outcomes |
Q57338131 | Association of polymorphisms in the mannose-binding lectin gene and pulmonary morbidity in preterm infants |
Q54271312 | Bacterial and fungal viability in the preterm gut: NEC and sepsis. |
Q34571294 | Bacterial diversity in two Neonatal Intensive Care Units (NICUs). |
Q36633476 | Bench-to-bedside review: Neonatal sepsis-redox processes in pathogenesis |
Q34102894 | Beyond bacteria: a study of the enteric microbial consortium in extremely low birth weight infants |
Q50187315 | Beyond sepsis: Staphylococcus epidermidis is an underestimated but significant contributor to neonatal morbidity |
Q93016798 | Bifidobacterium Supplementation of Colostrum and Breast Milk Enhances Weight Gain and Metabolic Responses Associated with Microbiota Establishment in Very-Preterm Infants |
Q35609805 | Birth weight independently affects morbidity and mortality of extremely preterm neonates |
Q90548314 | Blood culture indications in critically ill neonates: a multicenter prospective cohort study |
Q36164610 | Bloodstream infections in very low birth weight infants with intestinal failure. |
Q39359145 | Brain MRI measurements at a term-equivalent age and their relationship to neurodevelopmental outcomes |
Q43111592 | Brain injury caused by chronic fetal hypoxemia is mediated by inflammatory cascade activation |
Q50680469 | Brain injury in premature neonates: A primary cerebral dysmaturation disorder? |
Q37328165 | Brain-derived neurotrophic factor in infants <32 weeks gestational age: correlation with antenatal factors and postnatal outcomes |
Q36411049 | Burden of Invasive Staphylococcus aureus Infections in Hospitalized Infants. |
Q24186059 | C-reactive protein for diagnosing late-onset infection in newborn infants |
Q24200925 | Calling Time on Intravenous Immunoglobulin for Preterm Infants? |
Q37503327 | Can lactoferrin prevent neonatal sepsis and necrotizing enterocolitis? |
Q36184025 | Candida parapsilosis candidaemia in a neonatal unit over 7 years: a case series study |
Q35674518 | Center Variation in Intestinal Microbiota Prior to Late-Onset Sepsis in Preterm Infants |
Q30359381 | Cerebral ultrasound abnormalities in preterm infants caused by late-onset sepsis. |
Q27022056 | Cerebral white and gray matter injury in newborns: new insights into pathophysiology and management |
Q51597582 | Cerebrospinal fluid cytokines in the diagnosis of bacterial meningitis in infants. |
Q36120945 | Cerebrospinal fluid reference ranges in term and preterm infants in the neonatal intensive care unit |
Q90000681 | Challenges in developing a consensus definition of neonatal sepsis |
Q35221313 | Challenges in the diagnosis and management of neonatal sepsis |
Q37608259 | Changing definitions of long-term follow-up: Should "long term" be even longer? |
Q38921496 | Changing trend in bacterial etiology and antibiotic resistance in sepsis of intramural neonates at a tertiary care hospital |
Q35741709 | Characteristics of neonates with culture-proven bloodstream infection who have low levels of C-reactive protein (≦10 mg/L) |
Q43461579 | Characterization of chorioamnionitis in 2nd-trimester C-section placentas and correlation with microorganism recovery from subamniotic tissues |
Q34138000 | Choosing the right empirical antibiotics for neonates |
Q34667955 | Chorioamnionitis: implications for the neonate |
Q33805700 | Chronic fetal hypoxia produces selective brain injury associated with altered nitric oxide synthases |
Q33561756 | Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks' gestation |
Q34505582 | Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America |
Q34283108 | Clinical characteristics and response to prophylactic fluconazole of preterm VLBW neonates with baseline and acquired fungal colonisation in NICU: data from a multicentre RCT. |
Q41008958 | Clinical chorioamnionitis at term VI: acute chorioamnionitis and funisitis according to the presence or absence of microorganisms and inflammation in the amniotic cavity |
Q31134285 | Clinical data predict neurodevelopmental outcome better than head ultrasound in extremely low birth weight infants |
Q35614039 | Coagulase-negative staphylococcal infections in the neonatal intensive care unit |
Q43496826 | Coagulase-negative staphylococcus sepsis in preterm infants and long-term neurodevelopmental outcome |
Q49828346 | Cognitive Outcomes of Children Born Extremely or Very Preterm Since the 1990s and Associated Risk Factors: A Meta-analysis and Meta-regression |
Q91660086 | Common and distinct variation in data fusion of designed experimental data |
Q47977679 | Compared outcomes of very preterm infants born in 2000 and 2005. |
Q48230145 | Comparison of antibiotic dosing recommendations for neonatal sepsis from established reference sources |
Q47940326 | Complex interactions between hypoxia-ischemia and inflammation in preterm brain injury. |
Q34007957 | Compliance with prevention practices and their association with central line-associated bloodstream infections in neonatal intensive care units |
Q38161849 | Considerations in the pharmacologic treatment and prevention of neonatal sepsis. |
Q44221539 | Correct choices for correct treatments: key issues in the management of Candida infections in preterm neonates |
Q98564940 | Cost-effectiveness of probiotics for necrotizing enterocolitis prevention in very low birth weight infants |
Q60907362 | Creation of an Enhanced Recovery After Surgery (ERAS) Guideline for neonatal intestinal surgery patients: a knowledge synthesis and consensus generation approach and protocol study |
Q35328903 | Critical role for CXC ligand 10/CXC receptor 3 signaling in the murine neonatal response to sepsis. |
Q36777033 | Cytokine profiles of preterm neonates with fungal and bacterial sepsis. |
Q30422790 | Cytokine screening identifies NICU patients with Gram-negative bacteremia |
Q34886336 | Cytokines and perinatal brain damage |
Q38227951 | Decolonization to prevent Staphylococcus aureus transmission and infections in the neonatal intensive care unit |
Q39797571 | Decreasing infection in neonatal intensive care units through quality improvement |
Q36673792 | Defining neonatal sepsis |
Q35025582 | Delayed cord clamping in very preterm infants reduces the incidence of intraventricular hemorrhage and late-onset sepsis: a randomized, controlled trial |
Q24187497 | Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants |
Q24202657 | Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants |
Q24235703 | Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants |
Q24243153 | Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants |
Q34551755 | Detection and potential utility of C-reactive protein in saliva of neonates |
Q35981286 | Devastating coagulase-negative staphylococcal septicaemia in an extremely low birth weight infant |
Q64106107 | Development of a TaqMan Array card to target 21 purulent meningitis-related pathogens |
Q53514806 | Development of a statewide collaborative to decrease NICU central line-associated bloodstream infections. |
Q42025675 | Developmental regulation of Th17-cell capacity in human neonates |
Q36033641 | Diagnostic Value of Simultaneous Measurement of Procalcitonin, Interleukin-6 and hs-CRP in Prediction of Early-Onset Neonatal Sepsis |
Q45418430 | Diagnostic accuracy of neutrophil CD64 expression in neonatal infection: a meta-analysis |
Q30661333 | Diffusion magnetic resonance imaging in preterm brain injury. |
Q35204744 | Disparities in perinatal quality outcomes for very low birth weight infants in neonatal intensive care |
Q33655438 | DoMINO: Donor milk for improved neurodevelopmental outcomes. |
Q52009288 | Does necrotising enterocolitis impact the neurodevelopmental and growth outcomes in preterm infants with birthweight < or =1250 g? |
Q40003092 | Earlier initiation of enteral nutrition is associated with lower risk of late-onset bacteremia only in most mature very low birth weight infants. |
Q37629942 | Early Elevation in Interleukin-6 is Associated with Reduced Growth in Extremely Low Birth Weight Infants |
Q59808644 | Early Inflammatory Markers for the Diagnosis of Late-Onset Sepsis in Neonates: The Nosodiag Study |
Q37403938 | Early administration of oropharyngeal colostrum to extremely low birth weight infants. |
Q33559246 | Early and late onset sepsis in late preterm infants |
Q38114412 | Early enteral feeding strategies for very preterm infants: current evidence from Cochrane reviews |
Q92085944 | Early neonatal outcomes of very-low-birth-weight infants in Turkey: A prospective multicenter study of the Turkish Neonatal Society |
Q38046913 | Early onset sepsis in very low birth weight newborn infants |
Q24185956 | Early planned removal of umbilical venous catheters to prevent infection in newborn infants |
Q47826869 | Early planned removal of umbilical venous catheters to prevent infection in newborn infants. |
Q24185955 | Early planned removal versus expectant management of peripherally inserted central catheters to prevent infection in newborn infants |
Q57689098 | Early planned removal versus expectant management of peripherally inserted central catheters to prevent infection in newborn infants |
Q52660662 | Early progressive feeding in extremely preterm infants: a randomized trial. |
Q24234914 | Early removal versus expectant management of central venous catheters in neonates with bloodstream infection |
Q24239844 | Early removal versus expectant management of central venous catheters in neonates with bloodstream infection |
Q24185879 | Early removal versus expectant management of central venous catheters in neonates with bloodstream infection |
Q30487006 | Early-life programming of later-life brain and behavior: a critical role for the immune system |
Q37731006 | Economic evaluation of enhanced staff contact for the promotion of breastfeeding for low birth weight infants |
Q38730249 | Educational Performance of Children Born Prematurely |
Q36070592 | Effect of High-Dose Cysteine Supplementation on Erythrocyte Glutathione: A Double-Blinded, Randomized Placebo-Controlled Pilot Study in Critically Ill Neonates |
Q39458323 | Effect of Neuroinflammation on Synaptic Organization and Function in the Developing Brain: Implications for Neurodevelopmental and Neurodegenerative Disorders |
Q90148172 | Effect of early versus standard central line removal on growth of very low birthweight premature infants: a protocol for a non-inferiority randomised controlled trial |
Q40043975 | Effect of gestational age on the epidemiology of late-onset sepsis in neonatal intensive care units - a review |
Q89152010 | Effect of neonatal hyperoxia followed by concentrated ambient ultrafine particle exposure on cumulative learning in C57Bl/6J mice |
Q28596029 | Effect of provision of an integrated neonatal survival kit and early cognitive stimulation package by community health workers on developmental outcomes of infants in Kwale County, Kenya: study protocol for a cluster randomized trial |
Q44701193 | Effectiveness of a Guideline to Reduce Vancomycin Use in the Neonatal Intensive Care Unit |
Q30399789 | Effects of inter-alpha inhibitor proteins on neonatal brain injury: Age, task and treatment dependent neurobehavioral outcomes |
Q37307445 | Effects of interleukin-6 on the expression of tight junction proteins in isolated cerebral microvessels from yearling and adult sheep |
Q47327578 | Effects of neonatal enteral glutamine supplementation on cognitive, motor and behavioural outcomes in very preterm and/or very low birth weight children at school age. |
Q36071091 | Effects of recombinant human prolactin on breast milk composition |
Q35086075 | Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study. |
Q41081247 | Elevated plasma and cerebrospinal fluid interleukin-1 beta and tumor necrosis factor-alpha concentration and combined outcome of death or abnormal neuroimaging in preterm neonates with early-onset clinical sepsis. |
Q48114259 | Elevations of novel cytokines in bacterial meningitis in infants. |
Q91937986 | Enteral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates |
Q38704288 | Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants |
Q34328003 | Epidemic microclusters of blood-culture proven sepsis in very-low-birth weight infants: experience of the German Neonatal Network |
Q91502736 | Epidemiology and risk factors for recurrent Staphylococcus aureus colonization following active surveillance and decolonization in the NICU |
Q41996461 | Epidemiology of Invasive Fungal Disease in Children |
Q36203510 | Epidemiology of and risk factors for neonatal candidemia at a tertiary care hospital in western China |
Q94602484 | Epidemiology of neonatal infections in hospitals of Nepal: evidence from a large- scale study |
Q53690859 | Evaluation of a real-time PCR assay for detection and quantification of bacterial DNA directly in blood of preterm neonates with suspected late-onset sepsis. |
Q84286557 | Evaluation of a tool to screen at preschool age for minor cognitive disorders liable to affect schooling among children born premature |
Q40266645 | Evaluation of the (1,3)-β-D-glucan assay for the diagnosis of neonatal invasive yeast infections. |
Q36221493 | Evidence for complement activation in the amniotic fluid of women with spontaneous preterm labor and intra-amniotic infection |
Q37992218 | Evidence-based approach to preventing central line-associated bloodstream infection in the NICU. |
Q36939244 | Exchange Transfusion in the Treatment of Neonatal Septic Shock: A Ten-Year Experience in a Neonatal Intensive Care Unit |
Q30432149 | Executive summary of the workshop on infection in the high-risk infant |
Q40261366 | Exploring the Epidemiology of Hospital-Acquired Bloodstream Infections in Children in England (January 2009-March 2010) by Linkage of National Hospital Admissions and Microbiological Databases |
Q56372011 | Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials |
Q47191397 | Factors affecting development of motor skills in extremely low birth weight children |
Q35575131 | Factors influencing gastrointestinal tract and microbiota immune interaction in preterm infants. |
Q30414660 | Febrile illness and pro-inflammatory cytokines are associated with lower neurodevelopmental scores in Bangladeshi infants living in poverty |
Q36963107 | Fetal inflammatory response and brain injury in the preterm newborn |
Q43616704 | Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species |
Q37664330 | Fluconazole prophylaxis in high-risk neonates |
Q30457804 | Fluconazole prophylaxis in preterm infants: a multicenter case-controlled analysis of efficacy and safety |
Q37588245 | From selective vulnerability to connectivity: insights from newborn brain imaging |
Q38914048 | Genome-wide association study of sepsis in extremely premature infants |
Q47415700 | Gestational intermittent hypoxia increases susceptibility to neuroinflammation and alters respiratory motor control in neonatal rats |
Q27014745 | Glucocorticoids and preterm hypoxic-ischemic brain injury: the good and the bad |
Q24187294 | Glutamine supplementation for young infants with severe gastrointestinal disease |
Q24202112 | Glutamine supplementation for young infants with severe gastrointestinal disease |
Q24186930 | Glycerin laxatives for prevention or treatment of feeding intolerance in very low birth weight infants |
Q24200348 | Glycerin laxatives for prevention or treatment of feeding intolerance in very low birth weight infants |
Q34923905 | Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial |
Q36609479 | Group B Streptococcus and Escherichia coli infections in the intensive care nursery in the era of intrapartum antibiotic prophylaxis |
Q30442653 | Heart rate characteristics and clinical signs in neonatal sepsis |
Q36075145 | Heart rate variability analysis is more sensitive at identifying neonatal sepsis than conventional vital signs |
Q36157736 | Heteroresistant Vancomycin Intermediate Coagulase Negative Staphylococcus in the NICU: A Systematic Review |
Q43412923 | Histologic chorioamnionitis and acute neurologic impairment in premature infants |
Q34028660 | Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. |
Q38235712 | How long should umbilical venous catheters remain in place in neonates who require long-term (≥5-7 days) central venous access? |
Q36863445 | How to feed small for gestational age newborns. |
Q24246701 | Human recombinant activated protein C for severe sepsis in neonates |
Q44090632 | INH-A21: a donor-selected Staphylococcal human immune globulin for the prevention of late-onset neonatal Staphylococcal infection |
Q34086447 | Identification of a human neonatal immune-metabolic network associated with bacterial infection |
Q33561145 | Imaging selective vulnerability in the developing nervous system |
Q40297400 | Immuno-modulator inter-alpha inhibitor proteins ameliorate complex auditory processing deficits in rats with neonatal hypoxic-ischemic brain injury |
Q51838336 | Immunologic and infectious consequences of immediate versus delayed umbilical cord clamping in premature infants: a prospective, randomized, controlled study. |
Q38630222 | Immunologic biomarkers for diagnostic of early-onset neonatal sepsis. |
Q57175340 | Immunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and Future |
Q39690816 | Impact of a Central Line Infection Prevention Bundle in Newborn Infants |
Q36816483 | Impact of early human milk on sepsis and health-care costs in very low birth weight infants |
Q39818548 | Impact of healthcare-associated sepsis on mortality in critically ill infants |
Q37385422 | Impact of neonatal intensive care bed configuration on rates of late-onset bacterial sepsis and methicillin-resistant Staphylococcus aureus colonization |
Q35017381 | Implementation of a children's hospital-wide central venous catheter insertion and maintenance bundle |
Q36730658 | Improved survival and neurodevelopmental outcomes among extremely premature infants born near the limit of viability |
Q33810541 | Improving the use of human milk during and after the NICU stay |
Q49030219 | In vivo and in vitro evaluation of the effect of 2-(4-morpholinethyl)1-phenylcyclohexanecarboxylate on inflammation-sensitized hyperoxia-induced developing brain injury |
Q34782467 | Incidence of Late Onset Neonatal Sepsis in Very Low Birth Weight Infants in a Tertiary Hospital: An ongoing challenge |
Q52727783 | Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units. |
Q64101336 | Increased nurse workload is associated with bloodstream infections in very low birth weight infants |
Q42275242 | Inefficient antimicrobial functions of innate phagocytes render infant mice more susceptible to bacterial infection |
Q34130329 | Infection, Oxygen, and Immaturity: Interacting Risk Factors for Retinopathy of Prematurity |
Q34016458 | Infection-induced inflammation and cerebral injury in preterm infants |
Q35550564 | Infection-induced vulnerability of perinatal brain injury |
Q43253446 | Inflammation-induced preterm birth in a murine model is associated with increases in fetal macrophages and circulating erythroid precursors. |
Q36637831 | Inflammation-initiating illnesses, inflammation-related proteins, and cognitive impairment in extremely preterm infants |
Q37705471 | Inflammatory injury to the neonatal brain - what can we do? |
Q37184334 | Influence of gestational age on death and neurodevelopmental outcome in premature infants with severe intracranial hemorrhage |
Q31051254 | Innate immune deficiency of extremely premature neonates can be reversed by interferon-γ. |
Q37992220 | Inotropes in preterm infants--evidence for and against |
Q36267433 | Interleukin-1β transfer across the blood-brain barrier in the ovine fetus |
Q94446922 | Interneonatal intensive care unit variation in growth rates and feeding practices in healthy moderately premature infants |
Q56835384 | Intestinal Threonine Utilization for Protein and Mucin Synthesis Is Decreased in Formula-Fed Preterm Pigs |
Q30235377 | Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: a systematic review and meta-analysis. |
Q33781043 | Intranasal delivery of cell-penetrating anti-NF-κB peptides (Tat-NBD) alleviates infection-sensitized hypoxic-ischemic brain injury |
Q41385582 | Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia |
Q51947182 | Intrauterine infection with Ureaplasma species is associated with adverse neuromotor outcome at 1 and 2 years adjusted age in preterm infants. |
Q48276026 | Introduction of the American Pediatric Society's 2016 John Howland Award Recipient, Barbara J. Stoll, MD. |
Q33777640 | Invasive candidiasis in low birth weight preterm infants: risk factors, clinical course and outcome in a prospective multicenter study of cases and their matched controls |
Q37973390 | Invasive fungal infections during the neonatal period: diagnosis, treatment and prophylaxis |
Q48518321 | Ischemia reduces inter-alpha inhibitor proteins in the brain of the ovine fetus |
Q36150305 | JNK signaling is the shared pathway linking neuroinflammation, blood-brain barrier disruption, and oligodendroglial apoptosis in the white matter injury of the immature brain |
Q35010351 | Laboratory aid to the diagnosis and therapy of infection in the neonate |
Q38372967 | Lactoferrin and neonatology - role in neonatal sepsis and necrotizing enterocolitis: present, past and future |
Q39085772 | Lactoferrin and prematurity: a promising milk protein? |
Q38123550 | Lactoferrin and the newborn: current perspectives |
Q26471769 | Lactoferrin for the post-operative management of term neonates after gastrointestinal surgery |
Q58764142 | Lactoferrin: A Critical Player in Neonatal Host Defense |
Q35639587 | Language outcomes among ELBW infants in early childhood |
Q93000038 | Late Brain Involvement after Neonatal Immune Activation |
Q38215709 | Late-onset Ochrobactrum anthropi sepsis in a preterm neonate with congenital urinary tract abnormalities. |
Q40134410 | Late-onset Sepsis in Extremely Premature Infants: 2000-2011. |
Q35550706 | Late-onset neonatal sepsis: recent developments |
Q38347714 | Late-onset sepsis in preterm infants: update on strategies for therapy and prevention |
Q37695333 | Lifetime Modulation of the Pain System via Neuroimmune and Neuroendocrine Interactions. |
Q58920785 | Linking Early Adversity, Emotion Dysregulation, and Psychopathology: The Case of Extremely Low Birth Weight Infants |
Q88451231 | Long-Term Cognitive Outcomes After Sepsis: a Translational Systematic Review |
Q51743666 | Long-term characteristics of healthcare-associated infections in a neonatal intensive care unit. |
Q24594514 | Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review |
Q36756657 | Long-term outcome of brain structure in premature infants: effects of liberal vs restricted red blood cell transfusions |
Q30386333 | Long-term outcome of surgically managed necrotizing enterocolitis in a developing country. |
Q38636670 | Long-term outcomes of twins based on gestational age at delivery |
Q36717752 | Low-dose lipopolysaccharide selectively sensitizes hypoxic ischemia-induced white matter injury in the immature brain |
Q40716056 | Lymphocyte subpopulations in premature infants: an observational study |
Q64114921 | Machine learning models for early sepsis recognition in the neonatal intensive care unit using readily available electronic health record data |
Q37340565 | Management of neonatal sepsis by Gram-negative pathogens |
Q90371032 | Maternal activation of the EGFR prevents translocation of gut-residing pathogenic Escherichia coli in a model of late-onset neonatal sepsis |
Q35463640 | Maternal cytomegalovirus-specific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infants |
Q91314954 | Maternal immune activation: reporting guidelines to improve the rigor, reproducibility, and transparency of the model |
Q33774205 | Maternal or neonatal infection: association with neonatal encephalopathy outcomes |
Q37273381 | Meningitis in preterm neonates: importance of cerebrospinal fluid parameters |
Q38235134 | Meta-analysis shows that infants who have suffered neonatal sepsis face an increased risk of mortality and severe complications |
Q37632318 | Methicillin-resistant Staphylococcus aureus transmission and infections in a neonatal intensive care unit despite active surveillance cultures and decolonization: challenges for infection prevention. |
Q30492377 | Microbiologic and histologic characteristics of the extremely preterm infant's placenta predict white matter damage and later cerebral palsy. the ELGAN study |
Q47182945 | Microbiological monitoring of continuous positive airway pressure and resuscitation equipment in very-low birth weight infants |
Q91673977 | Microorganisms in the Placenta: Links to Early-Life Inflammation and Neurodevelopment in Children |
Q37463543 | Modelling the cost-effectiveness of human milk and breastfeeding in preterm infants in the United Kingdom. |
Q24188061 | Molecular assays for the diagnosis of sepsis in neonates |
Q30235563 | Molecular assays for the diagnosis of sepsis in neonates. |
Q99553119 | Molecular epidemiology of methicillin-susceptible Staphylococcus aureus in infants in a neonatal intensive care unit |
Q34206336 | Molecular microbiological methods in the diagnosis of neonatal sepsis |
Q51740472 | Morbidity and mortality of coagulase-negative staphylococcal sepsis in very-low-birth-weight infants. |
Q30457803 | More serious infectious morbidity and mortality associated with simultaneous candidemia and coagulase-negative staphylococcal bacteremia in neonates and in vitro adherence studies between Candida albicans and Staphylococcus epidermidis |
Q89600391 | Mortality and Neurodevelopmental Outcomes in the Heart Rate Characteristics Monitoring Randomized Controlled Trial |
Q34077073 | Multicenter study to determine antibody concentrations and assess the safety of administration of INH-A21, a donor-selected human Staphylococcal immune globulin, in low-birth-weight infants |
Q28472589 | Multidimensional proteomics analysis of amniotic fluid to provide insight into the mechanisms of idiopathic preterm birth |
Q92886369 | N-acetylcysteine inhibits bacterial lipopeptide-mediated neutrophil transmigration through the choroid plexus in the developing brain |
Q30434440 | Nearest-neighbor and logistic regression analyses of clinical and heart rate characteristics in the early diagnosis of neonatal sepsis |
Q36617416 | Necrotising enterocolitis |
Q51847395 | Necrotizing enterocolitis in infants with periventricular hemorrhagic infarction: associations and outcomes. |
Q34610528 | Neonatal Candidiasis: Epidemiology, Risk Factors, and Clinical Judgment |
Q37220111 | Neonatal E. coli infection causes neuro-behavioral deficits associated with hypomyelination and neuronal sequestration of iron |
Q30847961 | Neonatal Hypoxia Ischaemia: Mechanisms, Models, and Therapeutic Challenges |
Q46571495 | Neonatal Lipopolysaccharide Exposure Gender-Dependently Increases Heart Susceptibility to Ischemia/Reperfusion Injury in Male Rats. |
Q33766905 | Neonatal Procalcitonin Intervention Study (NeoPInS): Effect of Procalcitonin-guided decision making on duration of antibiotic therapy in suspected neonatal early-onset sepsis: A multi-centre randomized superiority and non-inferiority Intervention St |
Q42846077 | Neonatal coinfection model of coagulase-negative Staphylococcus (Staphylococcus epidermidis) and Candida albicans: fluconazole prophylaxis enhances survival and growth |
Q51861113 | Neonatal correlates of adverse outcomes in very low-birthweight infants in the NICU Network. |
Q34634864 | Neonatal gram negative and Candida sepsis survival and neurodevelopmental outcome at the corrected age of 24 months |
Q39941380 | Neonatal gram-negative infections, antibiotic susceptibility and clinical outcome: an observational study. |
Q26823812 | Neonatal host defense against Staphylococcal infections |
Q40269142 | Neonatal hyperglycaemia increases mortality and morbidity in preterm lambs |
Q63246147 | Neonatal infection leads to increased susceptibility to Aβ oligomer-induced brain inflammation, synapse loss and cognitive impairment in mice |
Q37267739 | Neonatal monocytes exhibit a unique histone modification landscape |
Q41501528 | Neonatal outcome of extremely preterm Asian infants ⩽28 weeks over a decade in the new millennium |
Q53966692 | Neonatal sepsis and simple minor neurological dysfunction. |
Q26824171 | Neonatal sepsis due to coagulase-negative staphylococci |
Q37416034 | Neonatal severe bacterial infection impairment estimates in South Asia, sub-Saharan Africa, and Latin America for 2010 |
Q34185611 | Neurodevelopment of extremely preterm infants who had necrotizing enterocolitis with or without late bacteremia |
Q47281720 | Neurodevelopmental evaluation of very low birth weight infants with sepsis at 18 to 24 months corrected age. |
Q50684922 | Neurodevelopmental impairment in preterm infants with late-onset infection: not only in extremely preterm infants. |
Q37204944 | Neurodevelopmental outcome of extremely low birth weight infants with Candida infection |
Q33578309 | Neurodevelopmental outcome of extremely low birth weight infants with posthemorrhagic hydrocephalus requiring shunt insertion |
Q37458922 | Neurodevelopmental outcomes in postnatal growth-restricted preterm infants with postnatal head-sparing |
Q37635926 | Neurodevelopmental outcomes of extremely low-gestational-age neonates with low-grade periventricular-intraventricular hemorrhage |
Q36598089 | Neurodevelopmental outcomes of neonates with medically and surgically treated necrotizing enterocolitis |
Q37405066 | Neurodevelopmental outcomes of premature infants with severe respiratory failure enrolled in a randomized controlled trial of inhaled nitric oxide |
Q38074829 | Neurodevelopmental outcomes of very low birth weight infants with neonatal sepsis: systematic review and meta-analysis |
Q46343042 | Neurological and developmental outcome of neonatal jaundice and sepsis in rural Kenya |
Q34443702 | Neurological complications after neonatal bacteremia: the clinical characteristics, risk factors, and outcomes |
Q38648972 | Neurological consequences of systemic inflammation in the premature neonate |
Q28074378 | Neurological sequelae of healthcare-associated sepsis in very-low-birthweight infants: Umbrella review and evidence-based outcome tree |
Q47992720 | Neutralizing anti-interleukin-1β antibodies reduce ischemia-related interleukin-1β transport across the blood-brain barrier in fetal sheep |
Q39023320 | Neutrophil and monocyte toll-like receptor 4, CD11b and reactive oxygen intermediates, and neuroimaging outcomes in preterm infants |
Q34104407 | New Concepts of Microbial Translocation in the Neonatal Intestine: Mechanisms and Prevention |
Q34178968 | New MR imaging assessment tool to define brain abnormalities in very preterm infants at term |
Q88873574 | New Threats from an Old Foe: Methicillin-Resistant Staphylococcus aureus Infections in Neonates |
Q35170480 | No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infants |
Q36744241 | Non-Nutritive Suck Parameter in Preterm Infants with RDS. |
Q64900668 | Nontypeable Haemophilus Influenzae Sepsis in a Term Neonate. |
Q47439543 | Normal birth weight variation and children's neuropsychological functioning: links between language, executive functioning, and theory of mind |
Q36688203 | Novel insights into molecular mechanisms of abruption-induced preterm birth |
Q37149991 | Nurse staffing and NICU infection rates |
Q90183050 | Nutrient Enrichment of Human Milk with Human and Bovine Milk-Based Fortifiers for Infants Born <1250 g: 18-Month Neurodevelopment Follow-Up of a Randomized Clinical Trial |
Q64060409 | One bout of neonatal inflammation impairs adult respiratory motor plasticity in male and female rats |
Q37381918 | Ontogeny of inter-alpha inhibitor proteins in ovine brain and somatic tissues |
Q24243750 | Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in premature infants |
Q24188043 | Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants |
Q24235455 | Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants |
Q24236014 | Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants |
Q24235911 | Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates |
Q24241292 | Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates |
Q24243599 | Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates |
Q92022057 | Oral nystatin prophylaxis to prevent systemic fungal infection in very low birth weight preterm infants: a randomized controlled trial |
Q36154652 | Oropharyngeal administration of mother's colostrum, health outcomes of premature infants: study protocol for a randomized controlled trial |
Q24186789 | Oropharyngeal colostrum in preventing mortality and morbidity in preterm infants |
Q57688800 | Oropharyngeal colostrum in preventing mortality and morbidity in preterm infants |
Q34526515 | Outcome at two years of age in a Swiss national cohort of extremely preterm infants born between 2000 and 2008. |
Q35672533 | Outcomes following candiduria in extremely low birth weight infants |
Q37713700 | Outcomes of extremely low birth weight infants with varying doses and intervals of antenatal steroid exposure |
Q59800488 | Oxidative Stress as a Primary Risk Factor for Brain Damage in Preterm Newborns |
Q37363805 | Oxidative burst and phagocytosis of neonatal neutrophils confronting Candida albicans and Candida parapsilosis |
Q36941006 | Pathogenesis of cerebral white matter injury of prematurity |
Q33940492 | Pathophysiology and treatment of septic shock in neonates. |
Q34441212 | Pattern of Blood Stream Infections within Neonatal Intensive Care Unit, Suez Canal University Hospital, Ismailia, Egypt |
Q24187349 | Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates |
Q24236202 | Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates |
Q24248766 | Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates |
Q24186610 | Percutaneous central venous catheters versus peripheral cannulae for delivery of parenteral nutrition in neonates |
Q38077729 | Perinatal and early postnatal factors underlying developmental delay and disabilities |
Q91173751 | Perinatal antibiotics alter preterm infant EEG and neurobehavior in the Family Nurture Intervention trial |
Q35624157 | Perinatal infection, inflammation, and retinopathy of prematurity |
Q36675587 | Permissive hyperglycemia in extremely low birth weight infants |
Q36053472 | Permissive hypotension in extremely low birth weight infants (≤1000 gm) |
Q90003240 | Persistent metagenomic signatures of early-life hospitalization and antibiotic treatment in the infant gut microbiota and resistome |
Q38215682 | Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants. |
Q43265333 | Pilot trial to compare tolerance of chlorhexidine gluconate to povidone-iodine antisepsis for central venous catheter placement in neonates |
Q35518931 | Placenta microbiology and histology and the risk for severe retinopathy of prematurity |
Q35017569 | Placental Microbiome and Its Role in Preterm Birth |
Q36167094 | Postnatal Age Is a Critical Determinant of the Neonatal Host Response to Sepsis |
Q37613751 | Postnatal infection is associated with widespread abnormalities of brain development in premature newborns |
Q43235334 | Postnatal sepsis, necrotizing entercolitis, and the critical role of systemic inflammation in white matter injury in premature infants |
Q89741613 | Precision medicine in perinatal depression in light of the human microbiome |
Q39226443 | Predicting death or tracheostomy placement in infants with severe bronchopulmonary dysplasia. |
Q34183129 | Predicting time to hospital discharge for extremely preterm infants |
Q90405088 | Prediction of Nonelective Central Venous Catheter Removal in Medically Complex Neonates |
Q35107249 | Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants |
Q50775885 | Prediction of cognitive abilities at the age of 5 years using developmental follow-up assessments at the age of 2 and 3 years in very preterm children. |
Q44098638 | Predictive factors for neuromotor abnormalities at the corrected age of 12 months in very low birth weight premature infants |
Q37649726 | Predictors of positive cerebrospinal fluid cultures in infants with bacteremia |
Q26773220 | Prenatal Alcohol Exposure and the Developing Immune System |
Q30612536 | Prenatal and postnatal inflammation in relation to cortisol levels in preterm infants at 18 months corrected age. |
Q35882560 | Presepsin (Soluble CD14 Subtype): Reference Ranges of a New Sepsis Marker in Term and Preterm Neonates |
Q94465234 | Prevalence and Associated Risk Factors of Sepsis among Neonates Admitted into Neonatal Intensive Care Units of Public Hospitals in Dhaka |
Q37356110 | Prevalence of Gram-negative bacteria in ventilator-associated pneumonia in neonatal intensive care units: a systematic review and meta-analysis protocol |
Q30235610 | Prevention and treatment of neonatal nosocomial infections. |
Q46459098 | Prevention of invasive Candida infections in preterm infants: the time is now. |
Q36334978 | Prevention of neonatal late-onset sepsis: a randomised controlled trial |
Q38614389 | Probiotics Prevent Late-Onset Sepsis in Human Milk-Fed, Very Low Birth Weight Preterm Infants: Systematic Review and Meta-Analysis |
Q36569565 | Probiotics and prebiotics: role in prevention of nosocomial sepsis in preterm infants |
Q24246036 | Probiotics for prevention of mortality and morbidity in preterm infants |
Q24197461 | Probiotics for prevention of necrotizing enterocolitis in preterm infants |
Q24235681 | Probiotics for prevention of necrotizing enterocolitis in preterm infants |
Q24242683 | Probiotics for prevention of necrotizing enterocolitis in preterm infants |
Q35263317 | Probiotics for prevention of necrotizing enterocolitis in preterm infants. |
Q34286789 | Profound lack of interleukin (IL)-12/IL-23p40 in neonates born early in gestation is associated with an increased risk of sepsis |
Q24245386 | Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical venous catheters |
Q24200249 | Prophylactic antibiotics to reduce morbidity and mortality in newborn infants with intercostal catheters |
Q24240973 | Prophylactic antibiotics to reduce morbidity and mortality in newborn infants with intercostal catheters |
Q41468190 | Prophylactic fluconazole in very low birth weight infants admitted to neonatal intensive care unit: randomized controlled trial |
Q24242582 | Prophylactic systemic antibiotics to reduce morbidity and mortality in neonates with central venous catheters |
Q24244417 | Prophylactic systemic antibiotics to reduce morbidity and mortality in neonates with central venous catheters |
Q35229922 | Protein A-neutralizing monoclonal antibody protects neonatal mice against Staphylococcus aureus |
Q28763858 | Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis |
Q89615294 | Randomized Controlled Trial of Bovine Lactoferrin for Prevention of Sepsis and Neurodevelopment Impairment in Infants Weighing Less Than 2000 Grams |
Q61796599 | Rapid Cerebral Metabolic Shift during Neonatal Sepsis Is Attenuated by Enteral Colostrum Supplementation in Preterm Pigs |
Q33827715 | Recent Advances in the Detection of Neonatal Candidiasis |
Q24200439 | Recombinant human activated protein C for severe sepsis in neonates |
Q24246064 | Recombinant human activated protein C for severe sepsis in neonates |
Q93138209 | Reducing catheter-related bloodstream infections in neonates - Authors' reply |
Q35738394 | Reducing ventilator-associated pneumonia in neonatal intensive care unit using "VAP prevention Bundle": a cohort study |
Q34732281 | Relationship Between Neonatal Blood Protein Concentrations and Placenta Histologic Characteristics in Extremely Low GA Newborns |
Q35527901 | Relationship between probable nosocomial bacteraemia and organisational and structural factors in UK neonatal intensive care units |
Q35011962 | Repeat lumbar punctures in infants with meningitis in the neonatal intensive care unit |
Q45300037 | Resuscitation intensity at birth is associated with changes in brain metabolic development in preterm neonates |
Q37631129 | Risk Factors for Health Care-Associated Bloodstream Infections in a Neonatal Intensive Care Unit |
Q92851821 | Risk Factors for Late-Onset Sepsis in Preterm Infants: A Multicenter Case-Control Study |
Q33927635 | Risk factors and prevention of late-onset sepsis in premature infants |
Q36625863 | Risk factors for invasive candidiasis in infants >1500 g birth weight |
Q36004614 | Risk factors for post-neonatal intensive care unit discharge mortality among extremely low birth weight infants |
Q28273111 | Risk factors for seizures in very low birthweight infants with periventricular leukomalacia |
Q36620426 | Risk factors of transfusion in anemia of very low birth weight infants. |
Q38635571 | Risk of morbidity following catheter removal among neonates with catheter associated bloodstream infection |
Q36395764 | Risk of parenteral nutrition in neonates--an overview |
Q38824418 | Role of lactoferrin in neonatal care: a systematic review |
Q34470700 | Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome |
Q47297706 | Route of infection alters virulence of neonatal septicemia Escherichia coli clinical isolates |
Q58776917 | Safety of Autologous Cord Blood Cells for Preterms: A Descriptive Study |
Q41660041 | Scrubbing the hub of intravenous catheters with an alcohol wipe for 15 sec reduced neonatal sepsis |
Q41136126 | Sepsis as a risk factor for neonatal morbidity in extremely preterm infants. |
Q59800492 | Sepsis-Induced Immunosuppression in Neonates |
Q30413017 | Septicemia mortality reduction in neonates in a heart rate characteristics monitoring trial |
Q87417915 | Serum Levels of Soluble Urokinase Plasminogen Activator Receptor in Infants with Late-onset Sepsis |
Q33838503 | Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. |
Q33563362 | Seven-month developmental outcomes of very low birth weight infants enrolled in a randomized controlled trial of delayed versus immediate cord clamping |
Q50530645 | Short versus Extended Duration of Trophic Feeding to Reduce Time to Achieve Full Enteral Feeding in Extremely Preterm Infants: An Observational Study. |
Q91726482 | Short- and Long-Term Neurodevelopmental Outcomes of Very Preterm Infants with Neonatal Sepsis: A Systematic Review and Meta-Analysis |
Q36599103 | Short- and Long-Term Outcomes for Extremely Preterm Infants. |
Q44029139 | Skin colonisation at the catheter exit site is strongly associated with catheter colonisation and catheter-related sepsis |
Q24186511 | Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants |
Q24187483 | Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants |
Q24198769 | Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants |
Q24235728 | Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants |
Q24243178 | Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants |
Q38602128 | Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants |
Q48206874 | Slower postnatal growth is associated with delayed cerebral cortical maturation in preterm newborns |
Q52592638 | Soluble TREM-1 as a predictive factor of neonatal sepsis: a meta-analysis. |
Q89505532 | Staphylococcus epidermidis in feedings and feces of preterm neonates |
Q30451728 | Strategies to Prevent Invasive Candidal Infection in Extremely Preterm Infants |
Q37784889 | Strategies to Prevent Ventilator-Associated Pneumonia in Neonates |
Q98210257 | Study on preventing adverse events in neonates (SEPREVEN): A stepped-wedge randomised controlled trial to reduce adverse event rates in the NICU |
Q40748451 | Success of Targeted Strategies to Reduce Methicillin-Susceptible Staphylococcus aureus Infections in the Neonatal Intensive Care Unit |
Q38960164 | Survival and Neurodevelopmental Outcomes among Periviable Infants. |
Q91370733 | Suspected or known neonatal sepsis and neurodevelopmental delay by 5 years |
Q36202757 | Sustained Reduction in Bloodstream Infections in Infants at a Large Tertiary Care Neonatal Intensive Care Unit |
Q40143612 | Syndrome Evaluation System (SES) versus Blood Culture (BACTEC) in the Diagnosis and Management of Neonatal Sepsis--A Randomized Controlled Trial |
Q40352006 | Systemic activation of Toll-like receptor 2 suppresses mitochondrial respiration and exacerbates hypoxic-ischemic injury in the developing brain |
Q47987658 | Systemic infusions of anti-interleukin-1β neutralizing antibodies reduce short-term brain injury after cerebral ischemia in the ovine fetus |
Q35803664 | Systemic responses of preterm newborns with presumed or documented bacteraemia |
Q93018229 | TNF-α antagonist attenuates systemic lipopolysaccharide-induced brain white matter injury in neonatal rats |
Q93078020 | The Influence of Early Nutrition on Brain Growth and Neurodevelopment in Extremely Preterm Babies: A Narrative Review |
Q64084328 | The Preterm Gut Microbiota: An Inconspicuous Challenge in Nutritional Neonatal Care |
Q40274453 | The Relationship of Maternal Prepregnancy Body Mass Index and Pregnancy Weight Gain to Neurocognitive Function at Age 10 Years among Children Born Extremely Preterm |
Q37263755 | The Role of Pancreatic Stone Protein in Diagnosis of Early Onset Neonatal Sepsis |
Q36262839 | The Speed of Increasing milk Feeds: a randomised controlled trial |
Q35349957 | The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. |
Q34098352 | The challenge of understanding cerebral white matter injury in the premature infant |
Q59329662 | The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review |
Q36016375 | The developing human preterm neonatal immune system: a case for more research in this area. |
Q34995998 | The developing oligodendrocyte: key cellular target in brain injury in the premature infant |
Q37560097 | The effect of granulocyte colony stimulating factor administration on preterm infant with neutropenia and clinical sepsis: a randomized clinical trial |
Q43328024 | The effect of neutral and acidic oligosaccharides on stool viscosity, stool frequency and stool pH in preterm infants |
Q98283594 | The effect of routine surveillance and decolonization on the rate of Staphylococcus aureus infections in a level IV neonatal intensive care unit |
Q26861652 | The epidemiology and diagnosis of invasive candidiasis among premature infants |
Q36633706 | The fear of necrotizing enterocolitis versus achieving optimal growth in preterm infants--an opinion |
Q44329672 | The fetal splenic vein flow pattern and fetal inflammatory response in the preterm prelabor rupture of membranes. |
Q30449556 | The immune system and developmental programming of brain and behavior |
Q40570495 | The impact of a sepsis quality improvement project on neurodisability rates in very low birthweight infants |
Q38913890 | The impact of inflammation on respiratory plasticity |
Q34270514 | The impact of prenatal and neonatal infection on neurodevelopmental outcomes in very preterm infants. |
Q33923319 | The impact of statistical choices on neonatal intensive care unit quality ratings based on nosocomial infection rates |
Q40430292 | Third Trimester Brain Growth in Preterm Infants Compared With In Utero Healthy Fetuses |
Q34666103 | Three-dimensional digital capture of head size in neonates - a method evaluation |
Q42370112 | Thyroid dysfunction in very low birth weight preterm infants |
Q90718790 | Time and dose-dependent impairment of neonatal respiratory motor activity after systemic inflammation |
Q33864692 | Time for a neonatal-specific consensus definition for sepsis. |
Q44674333 | Timely empiric antimicrobials are associated with faster microbiologic clearance in preterm neonates with late-onset bloodstream infections |
Q24186317 | Topical emollient for preventing infection in preterm infants |
Q31048823 | Topical ointment for preventing infection in preterm infants |
Q41894397 | Tractography-based quantitation of corticospinal tract development in premature newborns |
Q35557642 | Transcriptional modulation of intestinal innate defense/inflammation genes by preterm infant microbiota in a humanized gnotobiotic mouse model |
Q37315164 | Traumatic lumbar punctures in neonates: test performance of the cerebrospinal fluid white blood cell count |
Q36053721 | Treating Parents to Reduce NICU Transmission of Staphylococcus aureus (TREAT PARENTS) trial: protocol of a multisite randomised, double-blind, placebo-controlled trial. |
Q36676402 | Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. |
Q55004160 | Trends in the incidence and associated factors of late-onset sepsis associated with improved survival in extremely preterm infants born at 23-26 weeks' gestation: a retrospective study. |
Q35778242 | Types of Bacteria associated with Neonatal Sepsis in Al-Thawra University Hospital, Sana'a, Yemen, and their Antimicrobial Profile |
Q33795128 | Unimpaired outcomes for extremely low birth weight infants at 18 to 22 months |
Q35119052 | Unmyelinated white matter loss in the preterm brain is associated with early increased levels of end-tidal carbon monoxide |
Q38253204 | Use of lactoferrin in the newborn: where do we stand? |
Q36103605 | Use of the complete blood cell count in late-onset neonatal sepsis |
Q42268775 | Usefulness of urinary immune biomarkers in the evaluation of neonatal sepsis: a pilot project. |
Q33693432 | Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: added role of neonatal infection |
Q37390368 | Using proteomics in perinatal and neonatal sepsis: hopes and challenges for the future |
Q36291304 | Very low birth weight neonates who survive early-onset sepsis do not have an increased risk of developing late-onset sepsis |
Q30714640 | What brakes the preterm brain? An arresting story. |
Q93246819 | White matter injury predicts disrupted functional connectivity and microstructure in very preterm born neonates |
Q91921177 | White matter microstructure and cognitive outcomes in relation to neonatal inflammation in 6-year-old children born preterm |
Q46568003 | Why prevent invasive Candida infections? |
Search more.